Issta follow-up: The capital cost of the Israir seat deal
The Israir addendum turns part of Issta's tourism activity from a commission-and-distribution model into a much longer dollar commitment: an approximately $35 million advance amortized over 10 years, alongside a disclosed 2026 ticket-purchase advance of $51.5 million. That may deepen control over inventory and margin, but it also shifts more of the capital cost, working-capital burden, and execution dependence onto Issta.
The capital cost hiding inside the seat deal
The main article argued that Issta's value can no longer be read only through the tourism revenue line. This follow-up isolates the Israir seat agreement because this is where Issta changes not only a distribution channel, but also the capital profile of its tourism activity. The December 2024 agreement already gave Issta roughly 10% of the seats on every international flight marketed by Israir to the public, while Israir products continued to be distributed through Issta's retail activity for commissions. In December 2025 a very different layer was added: an allocation of 40 economy seats on every commercial flight operated by two Airbus-330 aircraft, an advance of about $35 million, and a 10-year offset period for that advance.
This is the core issue. Issta is no longer relying only on distribution commissions or on relatively shorter wholesale procurement. It is pre-paying for long-duration access to inventory, in dollars, while still remaining committed to buy the seats under an agreed pricing formula. If that works, control over product and margin should improve. If it works only partially, part of tourism growth turns into more expensive working capital and slower cash recovery.
The strategic logic is clear as well. The tourism chapter explicitly describes a strategy of buying tourism products on a wholesale basis to raise overall profitability and of building broader control over the value chain through strategic partnerships, including Israir. So this is not an accidental side move. It sits at the center of Issta's effort to replace part of the brokerage model with a model that controls the product. The problem is that the deeper the control, the higher the capital cost.
That chart does not necessarily mean the amounts add up to $86.5 million. It is not clarified whether the $35 million advance is embedded in the 2026 advance or sits alongside it. But something more important is clear: the Israir agreement is becoming larger, longer, and far more balance-sheet intensive than a normal commission model.
What actually changed in the economics
The original December 2024 agreement had already moved Issta one step deeper into the value chain. It was not only distributing Israir products in retail, but also receiving about 10% of the seats on every international flight marketed to the public for five years, buying them under an agreed formula for wholesale sale. That is already an inventory, pricing, and sell-through model rather than a pure commission model.
The December 2025 addendum changes both the scale and the character of the arrangement. Instead of a broader but relatively more flexible allocation, it ties Issta to 40 economy seats on every commercial flight of two Airbus-330 aircraft for 10 years, in return for an advance paid in instalments until February 10, 2026. In parallel, the parties agreed to extend the broader agreement through March 31, 2036 and to update the commercial terms, including a provision that the ticket-purchase advance under the agreement for 2026 will stand at $51.5 million.
So this no longer looks like a better marketing contract. It looks much closer to a contract in which Issta advances capital in order to secure long-duration access to product, and then has to earn that money back through seat margins over time.
| Layer | What was agreed | Why it matters |
|---|---|---|
| Retail model | Israir products continue to be distributed in retail for commissions | This is the light-capital layer, commission income without holding inventory |
| December 2024 agreement | About 10% of the seats on every international public flight for 5 years, purchased under an agreed formula | Issta already moves from brokerage toward an inventory and wholesale-margin model |
| December 2025 addendum | 40 economy seats on every commercial flight of two Airbus-330 aircraft, about $35 million advance, 10-year offset period | The inventory layer becomes longer and far more capital intensive |
| Parallel contract update | Extension through March 31, 2036 and a disclosed 2026 ticket-purchase advance of $51.5 million | The commitment becomes multi-year and much heavier on working capital |
This is not only a seat deal, it is also a capital-cost decision
The most important detail is that the advance is not described as a payment that replaces the seat price. On the contrary, the company still has to purchase the seats under an agreed pricing formula. That means the advance buys access and priority, but does not remove the ongoing procurement cost. The economics of the deal therefore have to justify not only the seat price, but also the time cost of money locked in upfront.
This is the point a first read can miss. A headline about seat allocation looks like a commercial growth lever. In practice, it is also a capital-allocation decision. For the agreement to be truly economic, the margin Issta earns from selling those seats has to cover not only the formula-based purchase price, but also the cost of carrying a dollar advance over a long period.
That also sharpens the question of what exactly Issta is funding. If tourism leaned only on distribution commissions, the main risks would be volume and price. Under the updated agreement, Issta is funding future access to inventory in advance, so it also carries duration risk, sell-through risk, and execution risk at the counterparty. Capital moves first, margin comes back later.
The protections exist, but they are only partial
There are two disclosed protections. First, if the two aircraft are not operated on trans-Atlantic flights, Issta may offset the advance against payments due to Israir under the agreement. Second, the advance will be secured by an Airbus-A3202 aircraft in Issta's favor.
That is not the same as eliminating risk. A right of offset against future payments is a commercial protection, but it is not the same thing as immediate cash recovery. For such an offset to work quickly, there still need to be future payments of the right scale, and the commercial relationship needs to keep running. The aircraft collateral sounds strong on paper, but without disclosure on the aircraft's value, lien ranking, or prior obligations, it is difficult to translate that into real economic coverage.
In other words, Issta did not receive only upside here. It also took on deeper dependence on Israir's execution, on the actual deployment of two wide-body aircraft, and on the quality of the collateral if that path turns out to be less smooth than planned.
What has to happen for the move to earn its keep
The deal can be attractive if it allows Issta to control sought-after inventory, sell it at a strong rate, and capture a larger share of the travel value chain. But for that to happen, several things need to show up quite soon.
First, the two Airbus-330 aircraft need to operate in practice on trans-Atlantic routes. Without that, the wide-body layer will not deliver the economics for which the advance was paid. Second, Issta needs to show that the seat allocation turns into margin, not only into volume. There is still no per-seat profitability metric here, so this remains the main open question until the activity starts showing up more clearly in results. Third, the disclosed $51.5 million ticket-purchase advance for 2026 means the test is not only theoretical and long-dated. The working-capital burden should become tangible already in the next cycle.
This is exactly where the deal reconnects with the broader Issta thesis. In the main article, tourism looked like an important growth engine, but not the group's only source of value. The Israir deal says that part of that growth now also consumes more capital. The real question is therefore not whether tourism grows, but whether it grows on terms that repay the capital locked against it.
Bottom line
The Israir seat agreement should not be read as just another commercial partnership expansion. It should be read as a transaction in which Issta chooses to pre-pay in order to secure deeper control over travel product. That can be a very good decision, but only if future margin justifies the capital, the time, and the execution risk.
That is the real test. Issta is trying to shift part of tourism from a brokerage model toward an inventory-control model. If it works, the company captures a larger share of the value chain. If it works only partially, part of future tourism profit will already have been pre-committed to advances, time, and counterparty execution.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.